Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-79

The Coldry process has been Validated and been significantly improved over the years. Recently there was a study resulting on the pellets gasification...

"Gasification testing with Newcastle University measured COLDry reactivity and conversion results, confirming high syngas and H2 yield, ideal for various downstream applications."

ECT have nailed the drying and are seeking an even better result so Id say they have succeeded with Coldry and now we should be well on our way with Ph2 construction. We were told that the options were holding ECTs shareprice back but they are now in the ELF and our market cap has an additional 800m shares added just incase ECT gets past 3c in the next few years...
So ECT has 2.47b shares on issue but 800m of those are listed only IF ECT gets to 3c

The way I look at it is ECT has 1.7b on issue at at MC of $15.3m @.009 or $17m at 1c (inc $2m of cash)

Looks like ECT are hiding the Top 20 again as it hasnt been published for 5 months, they rarely return calls and still no word on when they are going to start Ph2. ECT did a broker presentation 2 months ago saying they need a tiny $3.5m to get to $12m in revenue.... IMO we are none the wiser than this time last year.

There's been one volume smash down day of more than 10m on the 27th Feb and the last 10m plus volume smash downs occurred around 9 months ago.

Again, I ask - What is it the Governments or a large offtake partner don't like about ECT that we cant get funding to get to the revenue of $12m ?